We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $434M
1-Year Est. Return 9.09%
This Fund
S&P 500
This Quarter Est. Return
+0.54%
1 Year Est. Return
+9.09%
3 Year Est. Return
+56.86%
5 Year Est. Return
+84.63%
10 Year Est. Return
+238.52%
AUM
$406M
AUM Growth
-$9.45M
Cap. Flow
-$7.12M
Cap. Flow %
-1.75%
Top 10 Hldgs %
47.16%
Holding
60
New
2
Increased
19
Reduced
27
Closed
5

Top Buys

Rank Stock Value
1
G icon
Genpact
G
+$4.26M
2
BDX icon
Becton Dickinson
BDX
+$4.17M
3
BKNG icon
Booking.com
BKNG
+$3.36M
4
UNH icon
UnitedHealth
UNH
+$3.12M
5
WTW icon
Willis Towers Watson
WTW
+$2.25M

Top Sells

Rank Stock Value
1
AON icon
Aon
AON
+$5.04M
2
KVUE icon
Kenvue
KVUE
+$3.58M
3
JNJ icon
Johnson & Johnson
JNJ
+$3.4M
4
AXP icon
American Express
AXP
+$3.01M
5
META icon
Meta Platforms (Facebook)
META
+$2.72M

Sector Composition

Rank Sector Weight
1 Technology 27.02%
2 Healthcare 18.42%
3 Financials 14.26%
4 Consumer Staples 12.06%
5 Consumer Discretionary 10.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMXI icon
51
International Money Express
IMXI
$394M
$454K 0.11%
21,798
+1,658
+8% +$34.9K
XOM icon
52
ExxonMobil
XOM
$651B
$366K 0.09%
3,183
WEX icon
53
WEX
WEX
$6.35B
$354K 0.09%
1,996
+586
+42% +$120K
NSP icon
54
Insperity
NSP
$2.06B
$271K 0.07%
2,973
+226
+8% +$22.9K
SPNS
55
DELISTED
Sapiens International
SPNS
$248K 0.06%
7,317
+556
+8% +$18.1K
AON icon
56
Aon
AON
$78.3B
-15,110
Closed -$5.04M
EXP icon
57
Eagle Materials
EXP
$6.35B
-933
Closed -$254K
PFE icon
58
Pfizer
PFE
$142B
-69,262
Closed -$1.92M
ZBRA icon
59
Zebra Technologies
ZBRA
$13.7B
-1,018
Closed -$307K

Similar funds

Foyston, Gordon, & Payne's Q2 2024 Portfolio in Review

As of Q2 2024, Foyston, Gordon, & Payne held 60 positions worth $406M, down 2.3% from $415M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Foyston, Gordon, & Payne's Q2 2024 filing shows 2 new, 19 increased, 27 reduced and 5 closed positions. Its largest new stake was Genpact: 132,216 shares worth $4.26M. The largest sale was Aon, an estimated $5.04M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

  • Foyston, Gordon, & Payne's largest Q2 2024 buy was Genpact: 132,216 shares worth $4.26M.
  • Foyston, Gordon, & Payne added most to Becton Dickinson in Q2 2024, an estimated $4.17M increase.
  • Foyston, Gordon, & Payne's biggest Q2 2024 reduction was Kenvue, cutting an estimated $3.58M.
  • Foyston, Gordon, & Payne fully exited Aon in Q2 2024, selling an estimated $5.04M.
  • Foyston, Gordon, & Payne's ten largest holdings make up 47% of its $406M portfolio in Q2 2024.
  • Foyston, Gordon, & Payne opened 2 new positions and closed 5 in Q2 2024.
  • Foyston, Gordon, & Payne's portfolio value fell 2.3% quarter-over-quarter to $406M.

Based on Foyston, Gordon, & Payne's 13F filing for Q2 2024, filed 30 Jul 2024.